[PHARMA] QoQ Quarter Result on 30-Sep-2020 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Sep-2020 [#3]
Profit Trend
QoQ- -85.55%
YoY- 199.79%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 1,177,123 793,499 634,583 624,804 645,763 819,921 715,683 39.37%
PBT 22,244 31,524 -13,506 4,093 14,326 30,880 -238,474 -
Tax -8,356 -8,696 6,459 -2,799 -4,719 -8,465 59,741 -
NP 13,888 22,828 -7,047 1,294 9,607 22,415 -178,733 -
-
NP to SH 13,704 23,136 -6,331 1,442 9,979 22,399 -178,598 -
-
Tax Rate 37.57% 27.59% - 68.39% 32.94% 27.41% - -
Total Cost 1,163,235 770,671 641,630 623,510 636,156 797,506 894,416 19.16%
-
Net Worth 357,275 355,919 337,298 345,040 357,891 350,047 336,573 4.06%
Dividend
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Div 19,630 10,468 2,614 3,920 6,530 15,673 - -
Div Payout % 143.25% 45.25% 0.00% 271.91% 65.45% 69.98% - -
Equity
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Net Worth 357,275 355,919 337,298 345,040 357,891 350,047 336,573 4.06%
NOSH 261,991 261,705 261,705 261,705 261,705 261,229 261,229 0.19%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 1.18% 2.88% -1.11% 0.21% 1.49% 2.73% -24.97% -
ROE 3.84% 6.50% -1.88% 0.42% 2.79% 6.40% -53.06% -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 89.95 303.20 242.70 239.03 247.20 313.87 274.30 -52.47%
EPS 1.05 8.84 -2.42 0.55 3.82 8.57 -68.45 -
DPS 1.50 4.00 1.00 1.50 2.50 6.00 0.00 -
NAPS 0.273 1.36 1.29 1.32 1.37 1.34 1.29 -64.52%
Adjusted Per Share Value based on latest NOSH - 261,705
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 81.67 55.06 44.03 43.35 44.81 56.89 49.66 39.36%
EPS 0.95 1.61 -0.44 0.10 0.69 1.55 -12.39 -
DPS 1.36 0.73 0.18 0.27 0.45 1.09 0.00 -
NAPS 0.2479 0.247 0.234 0.2394 0.2483 0.2429 0.2335 4.07%
Price Multiplier on Financial Quarter End Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 -
Price 5.29 3.26 5.00 4.32 2.22 1.26 2.06 -
P/RPS 5.88 1.08 2.06 1.81 0.90 0.40 0.75 295.14%
P/EPS 505.18 36.88 -206.50 783.09 58.12 14.69 -3.01 -
EY 0.20 2.71 -0.48 0.13 1.72 6.81 -33.23 -
DY 0.28 1.23 0.20 0.35 1.13 4.76 0.00 -
P/NAPS 19.38 2.40 3.88 3.27 1.62 0.94 1.60 428.22%
Price Multiplier on Announcement Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 20/02/20 -
Price 0.925 4.03 3.49 5.72 4.42 1.88 2.04 -
P/RPS 1.03 1.33 1.44 2.39 1.79 0.60 0.74 24.68%
P/EPS 88.34 45.59 -144.14 1,036.87 115.71 21.93 -2.98 -
EY 1.13 2.19 -0.69 0.10 0.86 4.56 -33.55 -
DY 1.62 0.99 0.29 0.26 0.57 3.19 0.00 -
P/NAPS 3.39 2.96 2.71 4.33 3.23 1.40 1.58 66.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment